Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Freight Heights

Wednesday, March 4, 2015

Companies working in the field of pharmaceutical wholesale, have to be among the first to feel the effects of the crisis in the Russian economy. It began with a sharp bank loans cost increase. For distributors, who use factoring instruments and provide commodity loans to pharmacies, the cost of operating activities increased significantly. Furthermore, we came to the devaluation of national currency, luckily most contracts with suppliers, and hence, the payments are confirmed in rubles. This helped to avoid a collapse, but led to a revision of work principles. The share of short-term contracts grew significantly, price increase for all products, not included into VED list, is unavoidable.

However, there are also positive aspects. Excessive demand of December and January helped to clear stock, but in general, is a trifle in comparison how promising are perspectives of anti-crisis measures, which are being discussed at the level of the Russian Federation Government. The most serious consequences for the wholesale business will have a proposal to allow drugs parallel imports in Russia, in case it will be implemented. As a result, the importance of wholesalers should increase substantially, and the pressure from representative offices of foreign companies should reduce. But in this respect, real changes can be expected not earlier than 2017-2018.

Top 15 pharmaceutical distributors by shipments to final drugs recipients market share (including favorable supplies), in terms of value, following the results of 2014: